This hypothesis is reasonable, because we already confirmed that EP4 agonist treatment increased the intracellular Ca2+ concentration, and there are many reports that Ca2+ signaling regulates diverse cellular functions, including cancer cell migration10. This evidence concerns the gene PTGER4 and cancer.